Top 10 life-sciences-usa.com Wettbewerber

annualmeeting.hematology.org

The world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

bio-itworldexpo.com

Win Bio-IT World Best of Show Award 2026: Get community recognition for your breakthrough life sciences technology. People's Choice voting at Boston expo.

bioprocessingsummit.com

The Bioprocessing Summit unites a global community of scientists and engineers driving innovation and digitalization across process development, scale-up, quality, analytics for biologics, antibodies, cell and gene, and oligonucleotide therapies.

himssconference.com

Plan ahead for HIMSS26 by booking your hotel through our official partner, onPeak. Enjoy special rates, complimentary Wi-Fi, and peace of mind with flexible cancellation options.

pharming.com

Three decades of advancing care for rare disease communities. Learn about Pharming’s legacy, milestones, and mission.

immatics.com

Mathias Hothum joined Immatics’ board of directors in 2023 succeeding Dr. Friedrich von Bohlen und Halbach. Mathias is the managing director of dievini Hopp Biotech holding GmbH & Co. KG, the company managing the life science activities and investments of Dietmar Hopp, co-founder of SAP, and his family. He is currently also the founder/owner of HMM Consulting and the managing director of MSL Investments, DH Holding Verwaltungs, MH-LT-Investments and OH Venture Management. From 2001 to 2010, he additionally took the position of Lecturer in the Department of Economics at the University of Applied Sciences in Heidelberg. Mathias Hothum is Chairman of the Board of Joimax GmbH and Geuder AG, and board member of Apogenix AG, CureVac NV, Heidelberg Pharma AG, Molecular Health GmbH and Novaliq GmbH. Mathias Hothum holds a Diploma in business administration from the University of Mannheim, Germany, and a Ph.D. in pharmaceutical economics and medical sociology from […]

rakuten-med.com

楽天メディカルは、アルミノックス™プラットフォームと呼ばれる、特定の細胞に対し選択性に優れた新しい治療技術プラットフォームの開発を進めるバイオテクノロジー企業です。がんを克服するというミッションを掲げ、がん患者さんがより良い生活を送れる社会の実現を目指しています。

ir.corcept.com

The Investor Relations website contains information about Corcept Therapeutics, Incorporated's business for stockholders, potential investors, and financial analysts.